<SEC-DOCUMENT>0001140361-17-045018-index.html : 20171205
<SEC-HEADER>0001140361-17-045018.hdr.sgml : 20171205
<ACCEPTANCE-DATETIME>20171205125627
ACCESSION NUMBER:		0001140361-17-045018
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20171201
FILED AS OF DATE:		20171205
DATE AS OF CHANGE:		20171205

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			RAY DEBANJAN
		CENTRAL INDEX KEY:			0001706863

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37587
		FILM NUMBER:		171239177

	MAIL ADDRESS:	
		STREET 1:		C/O CYTOMX THERAPEUTICS, INC.
		STREET 2:		151 OYSTER POINT BLVD, SUITE 400
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CytomX Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001501989
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				273521219
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		151 OYSTER POINT BLVD.
		STREET 2:		SUITE 400
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650.515.3185

	MAIL ADDRESS:	
		STREET 1:		151 OYSTER POINT BLVD.
		STREET 2:		SUITE 400
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc1.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: doc1.html

Document 1 - RAW XML: doc1.xml

</DOCUMENT>
</SEC-DOCUMENT>